Gene fusions may be the 'smoking gun' in prostate cancer development

Prostate cancer treatments that target the hormone androgen and its receptor may be going after the wrong source, according to a new study. It suggests that the gene fusion -- not the androgen receptor -- is the real smoking gun that should be targeted by treatments.

Read the whole article on Science Daily

More from Science Daily